# Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine

> **NCT06873282** · PHASE2 · COMPLETED · sponsor: **Research Institute of Influenza, Russia** · enrollment: 160 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** TB/Flu-05E
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06873282
- **Lead sponsor:** Research Institute of Influenza, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-13
- **Primary completion:** 2024-01-12
- **Final completion:** 2024-04-11
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873282, "Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06873282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*